Galera Therapeutics Ownership 2024 | Who Owns Galera Therapeutics Now?
Institutional Ownership
21.96%
Insider Ownership
36.03%
Retail Ownership
42.01%
Institutional Holders
36.00
Galera Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| XTX TOPCO LTD | 0.10% | 0.00% | 52,113 | 26,867 | 106.42% | 7,129 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -24 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -1,391 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -69,029 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -106,564 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -448,330 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -757 | -100.00% | - | Jun 30, 2024 |
| MANCHESTER FINANCIAL INC | - | - | - | -72,000 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -2,831 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -32,720 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -35,403 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -440,349 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -76,630 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -3,632,627 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -357,192 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -22,020 | -100.00% | - | Jun 30, 2024 |
| BLACKSTONE INC. | - | - | - | -1,678,984 | -100.00% | - | Jun 30, 2024 |
| LPL FINANCIAL LLC | - | - | - | -18,102 | -100.00% | - | Jun 30, 2024 |
Galera Therapeutics's largest institutional shareholder is XTX TOPCO LTD, holding 0.10% of the company's total share outstanding, currently valued at $7.13K. The top 10 institutional shareholders own together 0.10% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| XTX TOPCO LTD | 0.10% | 0.00% | 52,113 | 26,867 | 106.42% | 7,129 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -24 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -1,391 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -69,029 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -106,564 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -448,330 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -757 | -100.00% | - | Jun 30, 2024 |
| MANCHESTER FINANCIAL INC | - | - | - | -72,000 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -2,831 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -32,720 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -35,403 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -440,349 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -76,630 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -3,632,627 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -357,192 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -22,020 | -100.00% | - | Jun 30, 2024 |
| BLACKSTONE INC. | - | - | - | -1,678,984 | -100.00% | - | Jun 30, 2024 |
| LPL FINANCIAL LLC | - | - | - | -18,102 | -100.00% | - | Jun 30, 2024 |
The largest Galera Therapeutics shareholder by % of total assets is XTX TOPCO LTD. The company owns 52.11K shares of Galera Therapeutics (GRTX), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| XTX TOPCO LTD | 0.10% | 0.00% | 52,113 | 26,867 | 106.42% | 7,129 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -24 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -757 | -100.00% | - | Jun 30, 2024 |
| LIFESTEPS FINANCIAL, INC. | - | - | - | -870 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -1,391 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -2,831 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | - | -7,867 | -100.00% | - | Jun 30, 2024 |
| J.W. COLE ADVISORS, INC. | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,143 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -15,782 | -100.00% | - | Jun 30, 2024 |
| LPL FINANCIAL LLC | - | - | - | -18,102 | -100.00% | - | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -22,020 | -100.00% | - | Jun 30, 2024 |
| LEVEL FOUR ADVISORY SERVICES, LLC | - | - | - | -26,441 | -100.00% | - | Jun 30, 2024 |
| GOOD LIFE ADVISORS, LLC | - | - | - | -31,250 | -100.00% | - | Jun 30, 2024 |
| KESTRA ADVISORY SERVICES, LLC | - | - | - | -32,250 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -32,720 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -35,403 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Galera Therapeutics's largest institutional buyer is XTX TOPCO LTD. The company purchased 26.87K stocks of GRTX, valued at $7.13K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | - | - | - | -3,632,627 | -100.00% | - | Jun 30, 2024 |
| BLACKSTONE INC. | - | - | - | -1,678,984 | -100.00% | - | Jun 30, 2024 |
| ABRDN PLC | - | - | - | -898,374 | -100.00% | - | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | - | - | - | -613,223 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -448,330 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -440,349 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -357,192 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -356,204 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -293,502 | -100.00% | - | Jun 30, 2024 |
| SUMMIT TRAIL ADVISORS, LLC | - | - | - | -147,658 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -106,564 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -76,630 | -100.00% | - | Jun 30, 2024 |
| MANCHESTER FINANCIAL INC | - | - | - | -72,000 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -69,029 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -35,403 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -32,720 | -100.00% | - | Jun 30, 2024 |
| KESTRA ADVISORY SERVICES, LLC | - | - | - | -32,250 | -100.00% | - | Jun 30, 2024 |
| GOOD LIFE ADVISORS, LLC | - | - | - | -31,250 | -100.00% | - | Jun 30, 2024 |
| LEVEL FOUR ADVISORY SERVICES, LLC | - | - | - | -26,441 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -22,020 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Galera Therapeutics's biggest institutional seller is GSA CAPITAL PARTNERS LLP. The company sold -3.63M shares of GRTX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | - | - | - | -3,632,627 | -100.00% | - | Jun 30, 2024 |
| BLACKSTONE INC. | - | - | - | -1,678,984 | -100.00% | - | Jun 30, 2024 |
| ABRDN PLC | - | - | - | -898,374 | -100.00% | - | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | - | - | - | -613,223 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -448,330 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -440,349 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -357,192 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -356,204 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -293,502 | -100.00% | - | Jun 30, 2024 |
| SUMMIT TRAIL ADVISORS, LLC | - | - | - | -147,658 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -106,564 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -76,630 | -100.00% | - | Jun 30, 2024 |
| MANCHESTER FINANCIAL INC | - | - | - | -72,000 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -69,029 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -35,403 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -32,720 | -100.00% | - | Jun 30, 2024 |
| KESTRA ADVISORY SERVICES, LLC | - | - | - | -32,250 | -100.00% | - | Jun 30, 2024 |
| GOOD LIFE ADVISORS, LLC | - | - | - | -31,250 | -100.00% | - | Jun 30, 2024 |
| LEVEL FOUR ADVISORY SERVICES, LLC | - | - | - | -26,441 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -22,020 | -100.00% | - | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| LPL FINANCIAL LLC | - | - | - | -18,102 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -15,782 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,143 | -100.00% | - | Jun 30, 2024 |
| J.W. COLE ADVISORS, INC. | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | - | -7,867 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -2,831 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -1,391 | -100.00% | - | Jun 30, 2024 |
| LIFESTEPS FINANCIAL, INC. | - | - | - | -870 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -757 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -24 | -100.00% | - | Jun 30, 2024 |
Galera Therapeutics's largest sold out institutional shareholder by shares sold is GSA CAPITAL PARTNERS LLP, sold -3.63M shares, valued at -, as of undefined.
Galera Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA HEALTHCARE INVESTORS | 0.35% | 296,462 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.27% | 125,773 | - | - | Mar 31, 2024 |
| Tekla Healthcare Opportunities Fund | 0.14% | 314,430 | - | - | Mar 31, 2024 |
| Tekla World Healthcare Fund | 0.13% | 161,709 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.11% | 58,500 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.05% | 108,200 | - | - | Mar 28, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.03% | 5,796 | - | - | Mar 28, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,457 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 14,122 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 404,866 | 235,648 | 139.26% | Feb 29, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 1,000 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 448,330 | -448,330 | -50.00% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 25,568 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 157,653 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 16,362 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 750 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 72 | - | - | Apr 30, 2021 |
| RUSSELL INVESTMENT CO | 0.00% | 22,262 | - | - | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 12,228 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 4,994 | - | - | Mar 28, 2024 |
| PGIM ETF TRUST | 0.00% | 2,174 | - | - | Feb 29, 2024 |
| Series Portfolios Trust | 0.00% | 178 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 1,600 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 190 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,705 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 61,359 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 4,150 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 28,707 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,286 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,225 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 9,613 | 1,906 | 24.73% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 6,797 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 88,262 | -2,336 | -2.58% | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 508 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 14,027 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 78 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 21,379 | - | - | Mar 28, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 946 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 35 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,103 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 3,645 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 2,832 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,597 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 965 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,605 | - | - | Feb 29, 2024 |
Galera Therapeutics's largest mutual fund holder by % of total assets is "TEKLA HEALTHCARE INVESTORS", owning 296.46K shares, compromising 0.35% of its total assets.
Galera Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 36 | - |
| 31 Dec, 23 | 36 | -7.69% |
| 30 Sep, 23 | 39 | -38.10% |
| 30 Jun, 23 | 63 | 46.51% |
| 31 Mar, 23 | 43 | 34.38% |
| 31 Dec, 22 | 32 | 6.67% |
| 30 Sep, 22 | 30 | -18.92% |
| 30 Jun, 22 | 37 | -22.92% |
| 31 Mar, 22 | 48 | - |
| 31 Dec, 21 | 48 | 23.08% |
| 30 Sep, 21 | 39 | -17.02% |
| 30 Jun, 21 | 47 | -12.96% |
| 31 Mar, 21 | 54 | 5.88% |
| 31 Dec, 20 | 51 | 15.91% |
| 30 Sep, 20 | 44 | 10.00% |
| 30 Jun, 20 | 40 | 17.65% |
| 31 Mar, 20 | 34 | 3.03% |
| 31 Dec, 19 | 33 | - |
As of 31 Mar 24, 36 institutions are holding Galera Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 9,781,943 | -24.40% |
| 31 Dec, 23 | 12,939,482 | 48.41% |
| 30 Sep, 23 | 8,718,797 | -53.05% |
| 30 Jun, 23 | 18,568,681 | -0.82% |
| 31 Mar, 23 | 18,721,781 | 56.41% |
| 31 Dec, 22 | 11,969,666 | 15.39% |
| 30 Sep, 22 | 10,373,178 | -1.37% |
| 30 Jun, 22 | 10,516,944 | -6.36% |
| 31 Mar, 22 | 11,231,333 | 1.48% |
| 31 Dec, 21 | 11,067,891 | -44.59% |
| 30 Sep, 21 | 19,973,259 | -2.58% |
| 30 Jun, 21 | 20,501,379 | 7.31% |
| 31 Mar, 21 | 19,103,999 | -0.90% |
| 31 Dec, 20 | 19,276,556 | 2.45% |
| 30 Sep, 20 | 18,815,816 | 0.50% |
| 30 Jun, 20 | 18,721,617 | 10.84% |
| 31 Mar, 20 | 16,891,125 | -0.62% |
| 31 Dec, 19 | 16,996,577 | - |
Galera Therapeutics (GRTX) has 9.78M shares outstanding as of 31 Mar 24, down -24.40% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 21.96% | 2.71% |
| 31 Dec, 23 | 28.45% | 6.89% |
| 30 Sep, 23 | 20.32% | 0.73% |
| 30 Jun, 23 | 52.76% | 1.86% |
| 31 Mar, 23 | 53.19% | 2.72% |
| 31 Dec, 22 | 44.19% | 2.95% |
| 30 Sep, 22 | 38.67% | 2.52% |
| 30 Jun, 22 | 39.21% | 2.22% |
| 31 Mar, 22 | 41.99% | 2.28% |
| 31 Dec, 21 | 42.92% | 0.74% |
| 30 Sep, 21 | 75.93% | 1.17% |
| 30 Jun, 21 | 80.71% | 1.38% |
| 31 Mar, 21 | 76.45% | 1.28% |
| 31 Dec, 20 | 77.24% | 1.35% |
| 30 Sep, 20 | 75.64% | 1.33% |
| 30 Jun, 20 | 75.39% | 1.63% |
| 31 Mar, 20 | 68.07% | 0.43% |
| 31 Dec, 19 | 126.00% | - |
As of 31 Mar 24, Galera Therapeutics is held by 21.96% institutional shareholders, representing a 2.71% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 12 | - |
| 31 Dec, 23 | 12 | -14.29% |
| 30 Sep, 23 | 14 | -65.00% |
| 30 Jun, 23 | 40 | 48.15% |
| 31 Mar, 23 | 27 | 200.00% |
| 31 Dec, 22 | 9 | 28.57% |
| 30 Sep, 22 | 7 | -12.50% |
| 30 Jun, 22 | 8 | -55.56% |
| 31 Mar, 22 | 18 | -30.77% |
| 31 Dec, 21 | 26 | 85.71% |
| 30 Sep, 21 | 14 | -36.36% |
| 30 Jun, 21 | 22 | -12.00% |
| 31 Mar, 21 | 25 | -10.71% |
| 31 Dec, 20 | 28 | 133.33% |
| 30 Sep, 20 | 12 | -60.00% |
| 30 Jun, 20 | 30 | 66.67% |
| 31 Mar, 20 | 18 | -45.45% |
| 31 Dec, 19 | 33 | - |
12 institutional shareholders have increased their position in GRTX stock as of 31 Mar 24 compared to 12 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 8 | - |
| 31 Dec, 23 | 8 | -38.46% |
| 30 Sep, 23 | 13 | 62.50% |
| 30 Jun, 23 | 8 | 100.00% |
| 31 Mar, 23 | 4 | -60.00% |
| 31 Dec, 22 | 10 | - |
| 30 Sep, 22 | 10 | -37.50% |
| 30 Jun, 22 | 16 | 45.45% |
| 31 Mar, 22 | 11 | 22.22% |
| 31 Dec, 21 | 9 | -18.18% |
| 30 Sep, 21 | 11 | -21.43% |
| 30 Jun, 21 | 14 | -12.50% |
| 31 Mar, 21 | 16 | 100.00% |
| 31 Dec, 20 | 8 | -42.86% |
| 30 Sep, 20 | 14 | 600.00% |
| 30 Jun, 20 | 2 | -75.00% |
| 31 Mar, 20 | 8 | - |
| 31 Dec, 19 | - | - |
8 institutional shareholders have reduced their position in GRTX stock as of 31 Mar 24 compared to 8 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 36 | - | 9,781,943 | -24.40% | 21.96% | 2.71% | 12 | - | 8 | - |
| 31 Dec, 23 | 36 | -7.69% | 12,939,482 | 48.41% | 28.45% | 6.89% | 12 | -14.29% | 8 | -38.46% |
| 30 Sep, 23 | 39 | -38.10% | 8,718,797 | -53.05% | 20.32% | 0.73% | 14 | -65.00% | 13 | 62.50% |
| 30 Jun, 23 | 63 | 46.51% | 18,568,681 | -0.82% | 52.76% | 1.86% | 40 | 48.15% | 8 | 100.00% |
| 31 Mar, 23 | 43 | 34.38% | 18,721,781 | 56.41% | 53.19% | 2.72% | 27 | 200.00% | 4 | -60.00% |
| 31 Dec, 22 | 32 | 6.67% | 11,969,666 | 15.39% | 44.19% | 2.95% | 9 | 28.57% | 10 | - |
| 30 Sep, 22 | 30 | -18.92% | 10,373,178 | -1.37% | 38.67% | 2.52% | 7 | -12.50% | 10 | -37.50% |
| 30 Jun, 22 | 37 | -22.92% | 10,516,944 | -6.36% | 39.21% | 2.22% | 8 | -55.56% | 16 | 45.45% |
| 31 Mar, 22 | 48 | - | 11,231,333 | 1.48% | 41.99% | 2.28% | 18 | -30.77% | 11 | 22.22% |
| 31 Dec, 21 | 48 | 23.08% | 11,067,891 | -44.59% | 42.92% | 0.74% | 26 | 85.71% | 9 | -18.18% |
| 30 Sep, 21 | 39 | -17.02% | 19,973,259 | -2.58% | 75.93% | 1.17% | 14 | -36.36% | 11 | -21.43% |
| 30 Jun, 21 | 47 | -12.96% | 20,501,379 | 7.31% | 80.71% | 1.38% | 22 | -12.00% | 14 | -12.50% |
| 31 Mar, 21 | 54 | 5.88% | 19,103,999 | -0.90% | 76.45% | 1.28% | 25 | -10.71% | 16 | 100.00% |
| 31 Dec, 20 | 51 | 15.91% | 19,276,556 | 2.45% | 77.24% | 1.35% | 28 | 133.33% | 8 | -42.86% |
| 30 Sep, 20 | 44 | 10.00% | 18,815,816 | 0.50% | 75.64% | 1.33% | 12 | -60.00% | 14 | 600.00% |
| 30 Jun, 20 | 40 | 17.65% | 18,721,617 | 10.84% | 75.39% | 1.63% | 30 | 66.67% | 2 | -75.00% |
| 31 Mar, 20 | 34 | 3.03% | 16,891,125 | -0.62% | 68.07% | 0.43% | 18 | -45.45% | 8 | - |
| 31 Dec, 19 | 33 | - | 16,996,577 | - | 126.00% | - | 33 | - | - | - |
Galera Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Galera Therapeutics's stock was made by Soffer Rochel on May 16 2024, selling - shares at - per share (valued at -). The last insider buy of GRTX was made by Schneid Yair on May 01 2024, buying 99,371 shares at $0.19 per share (worth $19.28K).
Galera Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2023 | 5 | - | - |
| Q1 2023 | 9 | - | - |
| Q4 2022 | 1 | 1 | 100.00% |
| Q3 2022 | 2 | 1 | 200.00% |
| Q2 2022 | 5 | - | - |
| Q1 2022 | 6 | - | - |
| Q4 2021 | 4 | 1 | 400.00% |
| Q3 2021 | 4 | 2 | 200.00% |
| Q2 2021 | 10 | - | - |
| Q1 2021 | 8 | 3 | 266.67% |
| Q4 2020 | 9 | 13 | 69.23% |
| Q2 2020 | 13 | 29 | 44.83% |
| Q1 2020 | 8 | - | - |
| Q4 2019 | 34 | 85 | 40.00% |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Galera Therapeutics's insiders, as of Q2 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2023 | - | - | - |
| Q1 2023 | 3 | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 1 | - | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | 5 | - | - |
| Q1 2021 | - | 1 | - |
| Q4 2020 | 1 | 5 | 20.00% |
| Q2 2020 | - | 20 | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 13 | - | - |
As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Galera Therapeutics's stocks.
Galera Therapeutics Peer Ownership
GRTX Ownership FAQ
Who Owns Galera Therapeutics?
Galera Therapeutics is owned by institutional shareholders (21.96%), insiders (36.03%), and public (42.01%). The largest institutional shareholder of Galera Therapeutics is XTX TOPCO LTD (0.10% of total shares) and the top mutual fund owner is TEKLA HEALTHCARE INVESTORS (0.35% of total shares).
Who are the major institutional shareholders of Galera Therapeutics?
Galera Therapeutics's major institutional shareholders are XTX TOPCO LTD, JPMORGAN CHASE & CO, US BANCORP \DE\, WELLS FARGO & COMPANY/MN, and NORTHERN TRUST CORP. The top five shareholders own together 0.10% of the company's share outstanding.
How many Galera Therapeutics shareholders are there?
As of Mar 2024, there are 36 institutional shareholders of Galera Therapeutics.
What percentage of Galera Therapeutics is owned by XTX TOPCO LTD?
XTX TOPCO LTD owns 52.11K shares of Galera Therapeutics, representing 0.10% of the company's total shares outstanding, valued at $7.13K (as of Jun 2024).
What percentage of Galera Therapeutics is owned by JPMORGAN CHASE & CO?
As of Jun 2024, JPMORGAN CHASE & CO holds 0 shares of Galera Therapeutics (GRTX), compromising 0% of the company, valued at $0.
What percentage of Galera Therapeutics is owned by US BANCORP \DE\?
US BANCORP \DE\ is the third largest holder of Galera Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).